Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer

被引:63
作者
López-Encuentra, A [1 ]
Astudillo, J [1 ]
Cerezal, J [1 ]
Gonzalez-Aragoneses, F [1 ]
Novoa, N [1 ]
Sánchez-Palencia, A [1 ]
机构
[1] Hosp Univ 12 Octubre, Pneumol Serv, Madrid 28041, Spain
关键词
lung cancer; chronic obstructive pulmonary disease; prognosis; conditional survival analysis; comorbidity; surgery;
D O I
10.1016/j.ejcts.2004.09.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Given the frequent association between chronic obstructive pulmonary disease (COPD) and lung cancer (I-C), the objective of this paper is to analyse the prognosis of this comorbidity. Methods: Multicenter prospective study compiling 2994 consecutive cases of surgically treated LC (1993-1997), the population with non-small cell lung cancer and complete resection was selected for the prognostic study of COPD. COPD is defined when the FEV1/FVC is < 0.7 (n = 1370; 46%). Overall and conditional survivals (survival likelihood when alive at 2, 3 or 5 years after treatment) as welt as the degree of severity (FEV1% percentiles) were calculated to establish prognosis. Results: Although the overall survival is similar whether or not COPD is present (Log-rank: 0.34), the conditional survival analysis is different in every stage at 60 months (Log-rank: 0.02) and different in stage pl at 24-36 months (Log-rank: 0.04). In LC (stage pl) with COPD, the presence of a worst pulmonary function (last FEV1% percentile vs first FEV1% percentile) is a bad prognostic factor (Log-rank: 0.002). Conclusions: The analysis of conditional survival at 24 months shows that COPD can be considered as a prognostic factor and that there is a clear relationship between the severity of the condition (FEV1%) and survival. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 25 条
[1]   Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer [J].
Battafarano, RJ ;
Piccirillo, JF ;
Meyers, BF ;
Hsu, HS ;
Guthrie, TJ ;
Cooper, JD ;
Patterson, GA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (02) :280-287
[2]   Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer [J].
Birim, Ö ;
Maat, APWM ;
Kappetein, AP ;
van Meerbeeck, JP ;
Damhuis, RAM ;
Bogers, AMC .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 23 (01) :30-34
[3]   Prognostic factors in non-small cell lung cancer - A decade of progress [J].
Brundage, MD ;
Davies, D ;
Mackillop, WJ .
CHEST, 2002, 122 (03) :1037-1057
[4]   Population impact of different definitions of airway obstruction [J].
Celli, BR ;
Halbert, RJ ;
Isonaka, S ;
Schau, B .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) :268-273
[5]   The "Will!Rogers" phenomenon.: Stage migration in bronchogenic carcinoma after applying certainty criteria [J].
Encuentra, AL ;
de la Cámara, AG ;
de Ugarte, AV ;
Mañes, N ;
Llobregat, N .
ARCHIVOS DE BRONCONEUMOLOGIA, 2002, 38 (04) :166-171
[6]  
Encuentra AL, 1998, LUNG CANCER, V20, P161
[7]  
FEINSTEIN AR, 1990, MEDICINE, V69, P1
[8]   RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER [J].
HOLMES, CE ;
RUCKDESCHEL, JC ;
JOHNSTON, M ;
THOMAS, PA ;
DESLAURIERS, J ;
GROVER, FL ;
HILL, LD ;
FELD, R ;
GINSBERG, RJ ;
MOUNTAIN, CF ;
DZUIBAN, S ;
KIELY, M ;
MCKNEALLY, MF ;
MOORES, DWO ;
RAMNES, C ;
WAGNER, H ;
BUNN, P ;
CHU, H ;
DIENHART, D ;
HAZUKA, M ;
KINZIE, J ;
SORENSEN, J ;
VANCE, V ;
BRAUN, T ;
HOPEMAN, A ;
KANE, M ;
RUSS, P ;
WHITMAN, GJR ;
FALL, SM ;
HANSEN, DP ;
HENDERSON, RH ;
MONCRIEF, CL ;
PAULING, F ;
SIMS, J ;
TELL, D ;
WISELYCARR, S ;
ABERNATHY, CM ;
CLARK, DA ;
MCCROSKEY, B ;
MOORE, G ;
MOORE, F ;
MYERS, A ;
WHITE, M ;
BROOKS, RJ ;
BULL, M ;
JOHNSON, FB ;
NEIMYR, M ;
PAQUETTE, FR ;
SACCOMANNO, G ;
LAD, T .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :615-622
[9]   Development of a comorbidity index using physician claims data [J].
Klabunde, CN ;
Potosky, AL ;
Legler, JM ;
Warren, JL .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (12) :1258-1267
[10]   Comorbidity in operable lung cancer -: A multicenter descriptive study on 2992 patients [J].
López-Encuentra, A .
LUNG CANCER, 2002, 35 (03) :263-269